Journal article 1663 views 2399 downloads
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, paralle...
Vanita R Aroda,
Steve Bain 
,
Bertrand Cariou,
Milivoj Piletič,
Ludger Rose,
Mads Axelsen,
Everton Rowe,
J Hans DeVries
,
Bertrand Cariou,
Milivoj Piletič,
Ludger Rose,
Mads Axelsen,
Everton Rowe,
J Hans DeVries
The Lancet Diabetes and Endocrinology, Volume: 5, Issue: 5, Pages: 355 - 366
Swansea University Author:
Steve Bain
-
PDF | Accepted Manuscript
Download (926.47KB)
DOI (Published version): 10.1016/S2213-8587(17)30085-2
Abstract
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
| Published in: | The Lancet Diabetes and Endocrinology |
|---|---|
| ISSN: | 22138587 |
| Published: |
2017
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa31639 |
| College: |
Faculty of Medicine, Health and Life Sciences |
|---|---|
| Issue: |
5 |
| Start Page: |
355 |
| End Page: |
366 |